These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7703548)

  • 41. [Treatment of 95 non-seminomatous germinal tumors of the testis].
    El Hafed A; Metz R; Dartois D
    Acta Chir Belg; 1980; 79(3):195-203. PubMed ID: 7190760
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Use of prognostic factors of disease progression in the treatment of patients with stage I nonseminomatous testicular tumors].
    Ondrus D
    Bratisl Lek Listy; 1999 Jan; 100(1):61-5. PubMed ID: 10493000
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Histopathologic risk factors in patients with non-seminomatous germ tumors of the testis in clinical stage 1. Retrospective study of 75 patients].
    Porcaro AB; Zecchini Antoniolli S; Novella G; Martignoni G; Bassetto MA; Poli A; Schiavone D; Tallarigo C; D'Amico A; Ficarra V; Curti P
    Arch Ital Urol Androl; 2001 Dec; 73(4):177-80. PubMed ID: 11822063
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Prognostic factors in genitourinary cancer].
    Kotake T; Miki T; Kuroda M
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2216-23. PubMed ID: 3408256
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Extratesticular extension of germ cell tumors preferentially occurs at the hilum.
    Dry SM; Renshaw AA
    Am J Clin Pathol; 1999 Apr; 111(4):534-8. PubMed ID: 10191775
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Flow-cytometric and quantitative histologic parameters as prognostic indicators for occult retroperitoneal disease in clinical-stage-I non-seminomatous testicular germ-cell tumors.
    De Riese WT; De Riese C; Ulbright TM; Walker EB; Messemer J; Jones JA; Reister T; Albers P; Allhoff EP; Foster RS
    Int J Cancer; 1994 Jun; 57(5):628-33. PubMed ID: 8194868
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognosis and other clinical correlates of pathologic review in stage I and II testicular carcinoma: a report from the Testicular Cancer Intergroup Study.
    Sesterhenn IA; Weiss RB; Mostofi FK; Stablein DM; Rowland RG; Falkson G; Rivkind SE; Vogelzang NJ
    J Clin Oncol; 1992 Jan; 10(1):69-78. PubMed ID: 1309382
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Aggressive surgical treatment of mediastinal and pulmonary metastasis of non-seminomatous testicular tumors].
    Lacquet LK; van de Wal HJ; Debruyne FM
    Ann Chir; 1988; 42(2):130-2. PubMed ID: 3369825
    [No Abstract]   [Full Text] [Related]  

  • 49. Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone.
    Freedman LS; Parkinson MC; Jones WG; Oliver RT; Peckham MJ; Read G; Newlands ES; Williams CJ
    Lancet; 1987 Aug; 2(8554):294-8. PubMed ID: 2886764
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Primitive neuroectodermal tumors arising in testicular germ cell neoplasms.
    Michael H; Hull MT; Ulbright TM; Foster RS; Miller KD
    Am J Surg Pathol; 1997 Aug; 21(8):896-904. PubMed ID: 9255252
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic risk factors in low stage testicular germ cell tumors: unanswered questions regarding clinically useful prognosticators for extratesticular disease.
    Herr HW
    Cancer; 1998 Jan; 82(1):230-2. PubMed ID: 9428504
    [No Abstract]   [Full Text] [Related]  

  • 52. Clinical stage I nonseminomatous and mixed germ cell tumors of the testis. A clinicopathologic study of 93 patients on a surveillance protocol after orchiectomy alone.
    Dunphy CH; Ayala AG; Swanson DA; Ro JY; Logothetis C
    Cancer; 1988 Sep; 62(6):1202-6. PubMed ID: 2842034
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum lactate dehydrogenase isoenzyme 1 and relapse in patients with nonseminomatous testicular germ cell tumors clinical stage I.
    von Eyben FE; Madsen EL; Blaabjerg O; Petersen PH; von der Maase H; Jacobsen GK; Rørth M
    Acta Oncol; 2001; 40(4):536-40. PubMed ID: 11504315
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bilateral testicular germ-cell tumors--a single centre long-term experience.
    Ondrus D; Hornák M; Mat'oska J
    Int Urol Nephrol; 2001; 33(3):521-4. PubMed ID: 12230287
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metastatic relapse after initial clinical stage I testicular Leydig cell tumor.
    Cost NG; Maroni P; Flaig TW
    Oncology (Williston Park); 2014 Mar; 28(3):211, 214. PubMed ID: 24855728
    [No Abstract]   [Full Text] [Related]  

  • 56. Vascular density does not predict future metastatic disease in clinical stage 1 non-seminomatous germ cell tumours of the testis.
    Maher TM; Lee AH
    Histopathology; 1998 Mar; 32(3):217-24. PubMed ID: 9568506
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic factors in cancer of the testis: an approach to identification.
    Goldman A; Bosl G; Johnson K; Fraley EE; Kennedy BJ
    Cancer Treat Rep; 1980; 64(2-3):487-96. PubMed ID: 7407788
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Significance of presence of teratomatous elements in the primary tumour of testicular cancer.
    Suzuki K; Nakazato H; Matsumoto K; Kurokawa K; Suzuki T; Suzuki K; Yamanaka H
    Int Urol Nephrol; 1998; 30(4):487-91. PubMed ID: 9821053
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Non-palpable testicular embryonal carcinoma diagnosed by ultrasound: a case report.
    Ishida M; Hasegawa M; Kanao K; Oyama M; Nakajima Y
    Jpn J Clin Oncol; 2009 Feb; 39(2):124-6. PubMed ID: 19066212
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic factors in clinical stage 1 non-seminomatous testicular tumours.
    Witjes JA; Spermon JR
    Curr Opin Urol; 2001 Sep; 11(5):531-4. PubMed ID: 11493776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.